These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7396316)

  • 1. Immunoglobulin replacement therapy by slow subcutaneous infusion.
    Berger M; Cupps TR; Fauci AS
    Ann Intern Med; 1980 Jul; 93(1):55-6. PubMed ID: 7396316
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
    Dams ET; van der Meer JW
    Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
    Gardulf A; Andersen V; Björkander J; Ericson D; Frøland SS; Gustafson R; Hammarström L; Jacobsen MB; Jonsson E; Möller G
    Lancet; 1995 Feb; 345(8946):365-9. PubMed ID: 7845120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency.
    Rojavin M; Sidhu J; Pfister M; Hubsch A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):146-8. PubMed ID: 25546799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Substitution therapy in immunologic deficiency syndromes].
    Iartsev MN; Gomes LA
    Pediatriia; 1989; (12):71-6. PubMed ID: 2628915
    [No Abstract]   [Full Text] [Related]  

  • 7. New choices for treatment with subcutaneous immunoglobulins.
    Pleguezuelo DE; Sánchez-Ramón S
    Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
    Sriaroon P; Ballow M
    Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.
    Canessa C; Iacopelli J; Pecoraro A; Spadaro G; Matucci A; Milito C; Vultaggio A; Agostini C; Cinetto F; Danieli MG; Gambini S; Marasco C; Trizzino A; Vacca A; De Mattia D; Martire B; Plebani A; Di Gioacchino M; Gatta A; Finocchi A; Licciardi F; Martino S; De Carli M; Moschese V; Azzari C
    Int J Immunopathol Pharmacol; 2017 Mar; 30(1):73-82. PubMed ID: 27927705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG replacement therapy, no size fits all.
    Bonilla FA
    Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem.
    Buckley RH
    J Clin Immunol; 1982 Apr; 2(2 Suppl):15S-21S. PubMed ID: 6806314
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of intravenous and subcutaneous human immunoglobulins].
    Ramus B; Benbrahim O; Chérin P
    Soins; 2019 Mar; 64(833):13-18. PubMed ID: 30879622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulins and immune deficiency: methods of administration].
    Suarez F
    Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?
    Baumann U; Miescher S; Vonarburg C
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):83-5. PubMed ID: 25546772
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulin replacement therapy.
    Sorensen RU; Polmar SH
    Ann Clin Res; 1987; 19(4):293-304. PubMed ID: 3314655
    [No Abstract]   [Full Text] [Related]  

  • 16. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
    Shapiro RS
    Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous immunoglobulin replacement in primary immunodeficiencies.
    Berger M
    Clin Immunol; 2004 Jul; 112(1):1-7. PubMed ID: 15207776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study.
    Vultaggio A; Azzari C; Milito C; Finocchi A; Toppino C; Spadaro G; Trizzino A; Baldassarre M; Paganelli R; Moschese V; Soresina A; Matucci A
    Clin Drug Investig; 2015 Mar; 35(3):179-85. PubMed ID: 25672929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.